Transgenic Group Inc. (TYO:2342)

Japan · Delayed Price · Currency is JPY

289.00

-1.00 (-0.34%)

At close: Mar 6, 2026

Revenue by Segment

Financials in millions JPY. Fiscal year is April - March.

Millions JPY. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017	Mar '16 Mar 31, 2016
Unallocated Adjustment Amount	-6.44M	-6.72M	-5.47M	-13.30M	-23.81M
Drug Discovery Support Business	1.90B	2.32B	2.25B	4.77B	3.58B
Drug Discovery Support Business Growth	-18.21%	2.89%	-52.74%	33.03%	-
Investment and Consulting Business	11.12B	10.77B	9.18B	-	-
Investment and Consulting Business Growth	3.19%	17.32%	-	-	-
TGBS Business - E-Commerce Business	-	-	-	4.70B	5.28B
TGBS Business - E-Commerce Business Growth	-	-	-	-11.05%	-0.94%
TGBS Business - Others	-	-	-	3.12B	2.20B
TGBS Business - Others Growth	-	-	-	41.77%	-24.69%
Total	13.01B	13.08B	11.43B	12.58B	11.05B
Total Growth	-0.60%	14.47%	-9.12%	13.85%	-0.00%

Revenue by Geography

Financials in millions JPY. Fiscal year is April - March.

Millions JPY. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017	Mar '16 Mar 31, 2016
Japan	13.01B	13.08B	11.43B	12.58B	11.05B
Japan Growth	-0.60%	14.47%	-9.12%	13.85%	0%
Total	13.01B	13.08B	11.43B	12.58B	11.05B
Total Growth	-0.60%	14.47%	-9.12%	13.85%	0%

Source: S&P Global Market Intelligence.